|
Volumn 46, Issue 1-2, 1995, Pages 181-194
|
Therapeutic effects of diethylcarbamazine and 3′-azido-3′-deoxythymidine on feline leukemia virus lymphoma formation
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CD4 ANTIGEN;
DIETHYLCARBAMAZINE;
PLACEBO;
VIRUS ANTIBODY;
ZIDOVUDINE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
CAT;
CONFERENCE PAPER;
CONTROLLED STUDY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FELINE LEUKEMIA VIRUS;
FLOW CYTOMETRY;
LYMPHOCYTE SUBPOPULATION;
LYMPHOCYTOPENIA;
LYMPHOMA;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
SURVIVAL RATE;
VIRUS INFECTION;
ANIMAL;
ANTIBODIES, VIRAL;
CAT DISEASES;
CATS;
COMPARATIVE STUDY;
DIETHYLCARBAMAZINE;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FLOW CYTOMETRY;
GENE PRODUCTS, GAG;
LEUKEMIA VIRUS, FELINE;
LEUKOCYTE COUNT;
LEUKOPENIA;
LYMPHOCYTES;
LYMPHOMA;
RANDOM ALLOCATION;
RETROVIRIDAE INFECTIONS;
RETROVIRIDAE PROTEINS, ONCOGENIC;
SPECIFIC PATHOGEN-FREE ORGANISMS;
SUPPORT, U.S. GOV'T, P.H.S.;
SURVIVAL RATE;
TUMOR VIRUS INFECTIONS;
VIRAL ENVELOPE PROTEINS;
ZIDOVUDINE;
|
EID: 0029070096
PISSN: 01652427
EISSN: None
Source Type: Journal
DOI: 10.1016/0165-2427(94)07017-2 Document Type: Article |
Times cited : (12)
|
References (24)
|